UBS Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.27M | Sell |
|
|||||
|
2025
Q2 | $3.81M | Buy |
|
|||||
|
2025
Q1 | $3.32M | Sell |
|
|||||
|
2024
Q4 | $4.41M | Buy |
|
|||||
|
2024
Q3 | $1.25M | Sell |
|
|||||
|
2024
Q2 | $1.85M | Buy |
|
|||||
|
2024
Q1 | $2.19M | Buy |
|
|||||
|
2023
Q4 | $2.38M | Buy |
|
|||||
|
2023
Q3 | $1.41M | Sell |
|
|||||
|
2023
Q2 | $1.64M | Buy |
|
|||||
|
2023
Q1 | $915K | Buy |
|
|||||
|
2022
Q4 | $561K | Buy |
|
|||||
|
2022
Q3 | $230K | Buy |
|
|||||
|
2022
Q2 | $129K | Buy |
|
|||||
|
2022
Q1 | $93K | Sell |
|
|||||
|
2021
Q4 | $532K | Buy |
|
|||||
|
2021
Q3 | $120K | Sell |
|
|||||
|
2021
Q2 | $382K | Buy |
|
|||||
|
2021
Q1 | $257K | Sell |
|
|||||
|
2020
Q4 | $351K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $6K | Sell |
|
|||||
|
2020
Q1 | $7K | Sell |
|
|||||
|
2019
Q4 | $40K | Buy |
|
|||||
|
2019
Q3 | $17K | Sell |
|
|||||
|
2019
Q2 | $199K | Buy |
|
|||||
|
2019
Q1 | $6K | Sell |
|
|||||
|
2018
Q4 | $578K | Buy |
|
|||||
|
2018
Q3 | $348K | Buy |
|
|||||
|
2018
Q2 | $125K | Buy |
|
|||||
|
2018
Q1 | $29K | Sell |
|
|||||
|
2017
Q4 | $34K | Sell |
|
|||||
|
2017
Q3 | $44K | Buy |
|
|||||
|
2017
Q2 | $45K | Buy |
|
|||||
|
2017
Q1 | $33K | Sell |
|
|||||
|
2016
Q4 | $526K | Buy |
|
|||||
|
2016
Q3 | $387K | Sell |
|
|||||
|
2016
Q2 | $370K | Sell |
|
|||||
|
2016
Q1 | $444K | Sell |
|
|||||
|
2015
Q4 | $615K | Buy |
|
|||||
|
2015
Q3 | $586K | Buy |
|
|||||
|
2015
Q2 | $614K | Buy |
|
|||||
|
2015
Q1 | $489K | Buy |
|
|||||
|
2014
Q4 | $44K | Buy |
|